2-(3-pyridin-2-yl-4-quinolin-4-yl-pyrazol-1-yl)-acetamide derivatives as inhibitors of the transforming growth factor beta receptor i / alk5
AL13693BActive Publication Date: 2026-09-23AGOMAB SPAIN S L U
0 Cites 0 Cited by
Patent Information
- Application Number
- AL2026421
- Authority / Receiving Office
- AL · AL
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2026-07-10
- Publication Date
- 2026-09-23
- Estimated Expiration
- 2046-07-10
Need to check novelty before this filing date? Find Prior Art
No text content released.